Non-Invasive Ventilation in Aspiration Pneumonitis/Pneumonia
Introduction to BiPAP
- The British Thoracic Society recommends BiPAP over CPAP for patients with aspiration pneumonitis and pneumonia who develop hypercapnia, as it provides superior ventilatory support for managing both hypoxemia and hypercapnia 1
- BiPAP's dual pressure levels (IPAP/EPAP) provide active ventilatory assistance during inspiration, which is critical when patients develop respiratory muscle fatigue or hypercapnia from the increased work of breathing associated with pneumonia 1
Rationale for BiPAP
- Aspiration pneumonia patients are at high risk for developing hypercapnic respiratory failure due to V/Q mismatch, increased dead space, and respiratory muscle fatigue from the inflammatory process 1
- The British Thoracic Society guidelines state that CPAP improves oxygenation in diffuse pneumonia, but NIV (BiPAP) should be used as an alternative to intubation if the patient becomes hypercapnic 1
Practical Implementation
- Verify the patient is NOT actively vomiting and CAN protect their airway before starting NIV 1
- Assess secretion burden and consider physiotherapy for sputum clearance before initiating NIV 5, 6
- Obtain baseline arterial blood gas to determine if hypercapnia (PaCO2 elevation) or acidosis (pH <7.35) is present 1
- Ensure patient is hemodynamically stable - life-threatening hypoxemia is a contraindication 1
Initial BiPAP Settings
- Start with IPAP 8-12 cmH2O and EPAP 4-5 cmH2O 3
- Maintain pressure differential of 4-6 cmH2O minimum (IPAP minus EPAP) 3
- Titrate FiO2 to maintain SpO2 85-90% in COPD patients or 90-96% in non-COPD patients 5, 3
Monitoring and Escalation
- Monitor SpO2 continuously for at least 24 hours after commencing NIV 5, 6
- Repeat arterial blood gas at 30-60 minutes after initiating BiPAP to assess response 3
- Reassess clinical status within 1-2 hours - do not delay intubation if patient is not improving 3